Cargando…
Cellular reprogramming to model and study epigenetic alterations in cancer
Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer develop...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768185/ https://www.ncbi.nlm.nih.gov/pubmed/33202305 http://dx.doi.org/10.1016/j.scr.2020.102062 |
_version_ | 1783629108355268608 |
---|---|
author | Kim, Jungsun |
author_facet | Kim, Jungsun |
author_sort | Kim, Jungsun |
collection | PubMed |
description | Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer development. Master transcription factor-mediated cellular reprogramming of human cancer cells allows us to model cancer progression. Here I cover the history and recent advances in reprogramming cancer cells, followed by lessons from cellular reprogramming of normal cells that may apply to cancer. Lastly, I share my perspective on cellular reprogramming for studying epigenetic alterations that have occurred in tumorigenesis, discuss the current limitations, and propose ways to overcome the obstacles in the reprogramming of cancer. |
format | Online Article Text |
id | pubmed-7768185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77681852020-12-30 Cellular reprogramming to model and study epigenetic alterations in cancer Kim, Jungsun Stem Cell Res Review Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer development. Master transcription factor-mediated cellular reprogramming of human cancer cells allows us to model cancer progression. Here I cover the history and recent advances in reprogramming cancer cells, followed by lessons from cellular reprogramming of normal cells that may apply to cancer. Lastly, I share my perspective on cellular reprogramming for studying epigenetic alterations that have occurred in tumorigenesis, discuss the current limitations, and propose ways to overcome the obstacles in the reprogramming of cancer. Elsevier 2020-12 /pmc/articles/PMC7768185/ /pubmed/33202305 http://dx.doi.org/10.1016/j.scr.2020.102062 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kim, Jungsun Cellular reprogramming to model and study epigenetic alterations in cancer |
title | Cellular reprogramming to model and study epigenetic alterations in cancer |
title_full | Cellular reprogramming to model and study epigenetic alterations in cancer |
title_fullStr | Cellular reprogramming to model and study epigenetic alterations in cancer |
title_full_unstemmed | Cellular reprogramming to model and study epigenetic alterations in cancer |
title_short | Cellular reprogramming to model and study epigenetic alterations in cancer |
title_sort | cellular reprogramming to model and study epigenetic alterations in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768185/ https://www.ncbi.nlm.nih.gov/pubmed/33202305 http://dx.doi.org/10.1016/j.scr.2020.102062 |
work_keys_str_mv | AT kimjungsun cellularreprogrammingtomodelandstudyepigeneticalterationsincancer |